Biagio Castaldi1,*, Giulio Cabrelle1, Massimo Padalino2, Vladimiro Vida2, Ornella Milanesi1, Giovanni Di Salvo1
Congenital Heart Disease, Vol.15, No.5, pp. 347-360, 2020, DOI:10.32604/CHD.2020.012750
Abstract Background: Trans-catheter closure has become the treatment of
choice for patent foramen ovale (PFO) and ostium secundum atrial septal defects
(ASD). A wide variety of devices are commercially available, however, concerns
have been raised about the risk of cardiac erosion associated with stiff/rigid
devices. The GORE® CARDIOFORM Septal Occluder (GSO) is a double-disc,
soft and conformable device with no reported incidence of cardiac erosions. However, wire frame fracture (WFF) have been reported. Aim: To assess the incidence
and clinical significance of WFF after GSO implantation in paediatric patients.
Methods: Seventy-seven consecutive patients were enrolled. Periprocedural and
follow-up assessments included clinical,… More >
Login
Register
